Tudor Investment Corp Portfolio holdings
AUM
$13.2B
This Quarter Return
+28.1%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$1.96B
AUM Growth
+$1.96B
(+93%)
Cap. Flow
+$758M
Cap. Flow
% of AUM
38.71%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
1,538
New
522
Increased
324
Reduced
248
Closed
401
Top Buys
| 1 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$84.4M |
| 2 |
IAC Inc
IAC
|
$58.5M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
$55.2M |
| 4 |
ADSW
Advanced Disposal Services, Inc.
ADSW
|
$43.8M |
| 5 |
PG&E
PCG
|
$38.5M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$110M |
| 2 |
RTX Corp
RTX
|
$24.3M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$17M |
| 4 |
iShares TIPS Bond ETF
TIP
|
$11.8M |
| 5 |
CY
Cypress Semiconductor
CY
|
$8.16M |
Sector Composition
| 1 | Financials | 19.06% |
| 2 | Technology | 16.95% |
| 3 | Communication Services | 10.84% |
| 4 | Industrials | 10.22% |
| 5 | Consumer Discretionary | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Waters Corp
WAT
$17.3B
| $2.27M | 0.11% |
+12,567
| New | +$2.27M |
|
|
SPLK
202
DELISTED
Splunk Inc
SPLK
| $2.27M | 0.11% |
11,410
+3,096
| +37% | +$615K |
|
203
Vertex Pharmaceuticals
VRTX
$102B
| $2.26M | 0.11% |
7,787
-2,585
| -25% | -$751K |
|
204
International Flavors & Fragrances
IFF
$16.8B
| $2.26M | 0.11% |
18,440
+9,055
| +96% | +$1.11M |
|
|
GMHIU
205
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
| $2.25M | 0.11% |
200,000
| – | – |
|
206
Allison Transmission
ALSN
$7.36B
| $2.25M | 0.11% |
61,196
+38,738
| +172% | +$1.42M |
|
207
Sarepta Therapeutics
SRPT
$1.98B
| $2.25M | 0.11% |
+14,034
| New | +$2.25M |
|
208
Yelp
YELP
$1.99B
| $2.24M | 0.11% |
96,877
+3,893
| +4% | +$90.1K |
|
209
Carnival Corp
CCL
$42.5B
| $2.24M | 0.11% |
136,368
+121,547
| +820% | +$2M |
|
210
Lockheed Martin
LMT
$105B
| $2.23M | 0.11% |
6,122
+3,904
| +176% | +$1.42M |
|
|
ARCE
211
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $2.22M | 0.11% |
+51,110
| New | +$2.22M |
|
212
Olin
OLN
$2.67B
| $2.22M | 0.11% |
+193,044
| New | +$2.22M |
|
213
CVS Health
CVS
$93B
| $2.22M | 0.11% |
+34,108
| New | +$2.22M |
|
214
Nektar Therapeutics
NKTR
$543M
| $2.21M | 0.11% |
95,287
+55,513
| +140% | +$1.29M |
|
215
Pultegroup
PHM
$26.3B
| $2.21M | 0.11% |
64,793
+39,793
| +159% | +$1.35M |
|
216
Spire
SR
$4.42B
| $2.2M | 0.11% |
33,548
+29,501
| +729% | +$1.94M |
|
|
ALXN
217
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.2M | 0.11% |
19,595
-4,502
| -19% | -$505K |
|
218
FIVE9
FIVN
$2.05B
| $2.19M | 0.11% |
19,804
+9,452
| +91% | +$1.05M |
|
219
Northrop Grumman
NOC
$83.2B
| $2.19M | 0.11% |
7,116
+4,585
| +181% | +$1.41M |
|
220
Pfizer
PFE
$141B
| $2.19M | 0.11% |
+66,810
| New | +$2.19M |
|
221
SolarEdge
SEDG
$1.97B
| $2.18M | 0.11% |
+15,698
| New | +$2.18M |
|
222
Verisk Analytics
VRSK
$37.5B
| $2.17M | 0.11% |
+12,758
| New | +$2.17M |
|
223
Gartner
IT
$18.8B
| $2.16M | 0.11% |
17,792
+10,065
| +130% | +$1.22M |
|
224
Allogene Therapeutics
ALLO
$249M
| $2.16M | 0.11% |
+50,399
| New | +$2.16M |
|
|
PLAN
225
DELISTED
Anaplan, Inc.
PLAN
| $2.16M | 0.11% |
47,555
+10,563
| +29% | +$479K |
|